| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8b148f4ca72e71acc4d3d37faa59e88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fff933bfcdf23b78231905bfea278da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91287ed56f686ef550107dc9ee4656e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb20da45653a7ac534c6cf23dfba72c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cc31104b8c7e31892cc68b9d0f7f04c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-743 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2005-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601873bda0d90ef9cd5a9b493c917234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ec317c134475ece58fad5455fcd0ba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d0b7d98464fd27a4c1132440ed89575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac9583064dcf4466d007ed412c5db89f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_730baeba66581da3684bac5842843a45 |
| publicationDate |
2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006045847-A1 |
| titleOfInvention |
Method for determination of anabolic activity |
| abstract |
Novel methods for determining the anabolic activity of a compound in muscle using microarrays to compare the in vivo changes of the genomic profile of mammalian muscle induced by a tested compound versus the corresponding changes induced by a known anabolic steroid. For example, in vivo changes of the genomic profile in the mouse induced by a tested compound may be compared to the genomic profile changes induced by the androgenic and anabolic steroid dihydrotestosterone (DHT). |
| priorityDate |
2004-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |